Cancer Biology and Oncology
A section of Biomedicines (ISSN 2227-9059).
Section Information
Scope
This section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumor and microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in the Pharmacology of Neuroendocrine Tumors (Deadline: 30 April 2024)
- Epigenetic Modulation for Cancer Therapy (Deadline: 30 April 2024)
- Prostate Cancer: From Drug Discover, Delivery to Resistance (Deadline: 30 April 2024)
- Tumor Microenvironment in Glioblastoma (Deadline: 30 April 2024)
- The Role of Inflammatory Cytokines in Cancer Progression 2.0 (Deadline: 30 April 2024)
- Molecular and Cellular Level of Pancreatic Cancer (Deadline: 30 April 2024)
- Killing It Softly–New Approaches to Overcome Cancer Chemoresistance 2.0 (Deadline: 30 April 2024)
- Tumor Microenvironment and Cancer Therapy (Deadline: 30 April 2024)
- Advances in the Pathogenesis and Treatment of Acute Myeloid Leukemia (Deadline: 30 April 2024)
- Estrogen for the Treatment and Prevention of Breast Cancer (Deadline: 30 April 2024)
- Novel Strategy for Treating Castration-Resistant Prostate Cancer (Volume II) (Deadline: 30 April 2024)
- Advances in Cancer Biology and Experimental Anticancer Therapies (Deadline: 30 April 2024)
- Signaling Pathways in Gynecological Malignant Tumors (Deadline: 31 May 2024)
- Personalized Medicine in Cancer Treatment: Apoptosis, Autophagy, and Drug Selection (Deadline: 31 May 2024)
- MicroRNAs as Mediators of Tumor Cell State Transitions, Receptor Remodeling, Drug Resistance, and Systemic Metastasis (Deadline: 31 May 2024)
- New Insights into Breast Cancer Management: From Tumorigenesis to Personalized Treatments (Deadline: 31 May 2024)
- New Insights into Upper Tract Urothelial Carcinoma: What Changed? (Deadline: 31 May 2024)
- The Role Precision Medicine in the Field of Cancer Oncology (Deadline: 31 May 2024)
- Advances in Targeting Genomics and the Tumor Immune System to Treat Gastrointestinal Cancers (Deadline: 31 May 2024)
- Application of Liposomes in Cancer (Deadline: 31 May 2024)
- Advances in Therapeutic Strategies in Gynecological Malignant Tumors (Deadline: 31 May 2024)
- The Biology of Circulating Tumor Cells 2.0 (Deadline: 15 June 2024)
- Pancreatic Cancer: From Mechanisms to Therapeutic Approaches (3rd Edition) (Deadline: 15 June 2024)
- Feature Reviews in Cancer Biomarkers (Deadline: 30 June 2024)
- Recent Advances in Ocular Oncology (Deadline: 30 June 2024)
- Targeting the Resistant Tumor Microenvironment in Lymphoma: From Basic Science to Artificial Intelligence (Deadline: 30 June 2024)
- Novel Insights on Cancer Stem Cells (Deadline: 30 June 2024)
- Cancer Metabolism and Resistance to Cell Death: Novel Therapeutic Perspectives 2nd Edition (Deadline: 30 June 2024)
- Molecular Targets in Cancer Cell Biology (Deadline: 30 June 2024)
- Immunotherapy for Urothelial Carcinoma: Milestones and Future Horizons (Deadline: 30 June 2024)
- Current Insights and Future Perspectives into Signaling Pathways and Mechanisms of Drug Resistance in Cancer (Deadline: 30 June 2024)
- Personalized Treatment in Cancer Research (Deadline: 30 June 2024)
- Resistance to Targeted Therapies in Human Cancer, 2nd Edition (Deadline: 30 June 2024)
- Tumor Viruses and Cancers: Carcinogenesis, Diagnosis, and Treatment Options (Deadline: 30 June 2024)
- Molecular Pathway Leading to Cancer Metastasis : Basic and Therapeutic Approach (Deadline: 30 June 2024)
- Understanding Cancer’s Inflammatory Crosstalk: The Potential for Precision Targeting (Deadline: 30 June 2024)
- Advances in Immunotherapy and Radiation Therapy for Cancer (Deadline: 30 June 2024)
- Role of Autophagy in Cancer Physiological Mechanism (Deadline: 30 June 2024)
- The Role of NK Cells in Hematological Malignancies (Deadline: 30 June 2024)
- Advancing Cancer Immunotherapy: Unleashing the Potential of the Immunological Synapse (Deadline: 30 June 2024)
- Gastric Cancer: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 30 June 2024)
- Roles of T Cells in Immunotherapy (Deadline: 30 June 2024)
- Recent Advances in Lymphoma (Deadline: 30 June 2024)
- Advancements in Synthetic Small Molecules as Anti-cancer Therapeutics (Deadline: 30 June 2024)
- Intrinsic Metabolic Factors in Non-small Cell Lung Cancer (Deadline: 15 July 2024)
- Drug Resistance and Novel Targets for Cancer Therapy—Second Edition (Deadline: 31 July 2024)
- Molecular Targets to Enhance the Radiation Effect and Overcome Radiation Resistance in Cancer (Deadline: 31 July 2024)
- Role of Bone Marrow Niche in Haematological Cancers (Deadline: 31 July 2024)
- Novel Approaches towards Targeted Head and Neck Cancer Therapies (Deadline: 31 July 2024)
- Mechanisms and Novel Therapeutic Approaches for Gliomas (Deadline: 31 July 2024)
- Understanding Non-small Cell Lung Cancer: Biology, Therapeutics and Drug Resistance (Deadline: 31 July 2024)
- RAS Signaling in Cancer (Deadline: 31 July 2024)
- Glioblastoma: Current Status and Future Prospects (Deadline: 31 July 2024)
- Cutaneous Oncology—From Risk Factors to Prognosis of Skin Cancer (Deadline: 31 July 2024)
- Oral Squamous Cell Carcinoma: Molecular Signaling Pathways and Novel Biomarkers (Deadline: 31 July 2024)
- Advanced Cancer Diagnosis and Treatment: Second Edition (Deadline: 31 August 2024)
- Emerging Perspectives on Breast Cancer and Antibody–Drug Conjugates Treatment: From Bench to Bedside (Deadline: 31 August 2024)
- Molecular Biology and New Therapeutic Approaches to Cancer (Deadline: 31 August 2024)
- NASH and Hepatocellular Carcinoma (HCC) (Deadline: 31 August 2024)
- An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology (Deadline: 31 August 2024)
- Advancements in Lung Cancer Precision Oncology Research and Treatments (Deadline: 31 August 2024)
- Molecular Research and New Therapy in Melanoma (Deadline: 31 August 2024)
- Two Decades of Progress in the Prevention and Treatment of Colorectal Cancer: From Aspirin to Targeted Therapy (Deadline: 31 August 2024)
- Head and Neck Tumors, 3rd Edition (Deadline: 31 August 2024)
- Biomarkers and Targeted Drugs for Colorectal Cancer (Deadline: 31 August 2024)
- Pathogenesis, Disease Detection and Novel Therapeutic Approaches for Osteosarcoma (Deadline: 31 August 2024)
- CDK Inhibitors: A New Wave of Cancer Therapy (Deadline: 31 August 2024)
- Head-and-Neck Sarcomas: Exploring Ways for Their Optimal Treatment (Deadline: 30 September 2024)
- Pancreatic Cancer: Pathomechanism, Diagnostics and Novel Treatment Options (Deadline: 30 September 2024)
- Urogenital Cancers: New Molecular and Translational Aspects on Carcinogenesis and Treatments (Deadline: 30 September 2024)
- Endometrial Cancer: From Pathobiology to Treatment (Deadline: 30 September 2024)
- Current Insights and Future Perspectives into Mechanisms of Drug Resistance in Gastrointestinal Cancers (Deadline: 30 September 2024)
- Advances in the Treatment of Kidney and Upper Urinary Tract Cancers: Second Edition (Deadline: 30 September 2024)
- Early Diagnosis and Targeted Therapy of Pancreatic Cancer (Deadline: 30 September 2024)
- Prostate Cancer Targeted Therapy: Highlighting Advances in Precision Medicine and Rational Combination Approaches (Deadline: 30 September 2024)
- Mitochondria and Immunometabolism in Cancer (Deadline: 30 September 2024)
- Mechanisms and Novel Therapeutic Approaches for Colorectal Cancer (Deadline: 30 September 2024)
- From Bench to Bedside: Advances in Non-small Cell Lung Cancer in the Era of Precision Oncology (Deadline: 30 September 2024)
- Advancements in Artificial Intelligence (AI) for Cancer Genomics and Genetics (Deadline: 30 September 2024)
- New Advance in Whole Genome Sequencing Analysis for Early Cancer Detection (Deadline: 30 September 2024)
- Diagnosis, Pathogenesis and Treatment of Pancreatic Ductal Adenocarcinoma (Deadline: 30 September 2024)
- Hereditary Breast Cancer and BRCA Genes (Deadline: 30 September 2024)
- Advances in Molecular Mechanisms of Head and Neck Cancers (Deadline: 30 September 2024)
- New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma (Deadline: 30 September 2024)
- Past, Present and Further Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (Deadline: 30 September 2024)
- Application and Nanotechnologies in 3D Bioprinting Models for Personalized Cancer Treatment (Deadline: 30 September 2024)
- Novel Approaches for Diagnosis and Treatment of Pancreatic Cancer (Deadline: 30 September 2024)
- Antibody–Drug Conjugates and Cancer Immunotherapy (Deadline: 25 October 2024)
- Molecular Mechanisms of Myeloid Cell Differentiation and Resistance to Anti-tumor Immunity (Deadline: 31 October 2024)
- Genomic Insights and Translational Opportunities for Human Cancers (Deadline: 31 October 2024)
- Malignant and Potentially Malignant Disorders of the Oral Cavity: Updates from Pathogenesis to Therapy 2.0 (Deadline: 31 October 2024)
- Targeting Transcription Factors and Oncogenic Proteins for Cancer Therapy 2.0 (Deadline: 31 October 2024)
- Biological Imaging in Tumor Microenvironment (Deadline: 31 October 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Autophagy in Cancer and Metastasis
- Feature Papers in Cancer Biology and Therapeutics
- Hereditary Gastrointestinal Cancer Syndromes: Molecular Basis of Onset and Progression, Molecular Diagnosis, and Precision Therapy
- Stem Cells and Cancer Therapeutics (Closed)
- Targeting Cell Metabolism as Cancer Therapy (Closed)
